Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting

Clinical trial NCT06324734 · COMPLETED

Trial details

NCT number: NCT06324734
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE

Start date: 2024-04-29
Primary completion: 2024-07-15
Enrollment: 2506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.